수의학 항생제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00022340
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

시장 소개

동물용 항생제는 동물의 질병을 치료, 통제 또는 예방하는 데 사용됩니다. 이들은 또한 성장 촉진제로 사용되며 동물의 건강을 유지하는 데 중요한 역할을 합니다. 항생제는 일반적으로 박테리아에 직접적인 효과를 주어 농장과 반려동물의 감염을 예방하는 항균 화합물입니다. 우유, 계란, 육류에 대한 수요 증가와 함께 인간의 항생제 내성에 대한 우려가 커지면서 전 세계 수의학 항생제 시장에 영향을 미치고 있습니다.

시장 역학
< br />동물용 항생제 시장의 성장을 이끄는 요인은 동물성 질병의 높은 우세와 전 세계적으로 증가하는 예방접종의 중요성입니다. 그러나 항생제 내성에 대한 위협이 증가하고 FDA가 부과하는 엄격한 규제로 인해 시장 성장이 저해될 가능성이 높습니다. 더욱이, 수의학 항생제의 의료 지출과 결합된 애완동물 건강 보험에 대한 수요 증가는 시장에서 성장 기회를 창출할 가능성이 더욱 높습니다.

시장 범위

"2031년까지의 수의학 항생제 시장 분석"은 특별한 초점을 맞춘 의료 산업에 대한 전문적이고 심층적인 연구입니다. 글로벌 시장 동향 분석에 대해 알아봅니다. 이 보고서는 제품, 제형 및 최종 용도별로 상세한 시장 세분화를 통해 동물용 항생제 시장에 대한 개요를 제공하는 것을 목표로 합니다. 동물용 항생제 시장은 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다. 이 보고서는 동물용 항생제 시장의 주요 업체의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.

시장 세분화

동물용 항생제 시장은 제품, 제제 및 최종 용도를 기준으로 분류됩니다. 제품에 따라 시장은 구충제, 항균제, 비스테로이드성 항염증제 등으로 분류됩니다. 제형을 기준으로 시장은 프리믹스, 주사제, 경구 분말, 경구 용액 등으로 분류됩니다. 최종 용도를 기준으로 시장은 농장 동물, 반려 동물 등으로 분류됩니다.



보고서는 다음을 제공합니다. 정성적, 정량적 정보를 모두 포함한 업계의 자세한 개요. 다양한 부문을 기반으로 한 수의학 항생제 시장에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역에 대해 2021년부터 2031년까지 시장 규모와 예측 추정치를 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남부 & 중앙 아메리카. 각 지역별 수의학 항생제 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 이 지역에 널리 퍼져 있는 현재 추세 및 기회를 다루고 있습니다.

이 보고서는 수요와 공급 측면에서 동물용 항생제 시장에 영향을 미치는 요인을 분석하고 추가로 시장 역학에 영향을 미치는 것을 평가합니다. 예측 기간 동안의 시장, 즉 동인, 제한 사항, 기회 및 미래 추세. 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 북미, 유럽, APAC, MEA 및 남부 & 중앙아메리카는 이 지역의 동물용 항생제 시장에 영향을 미치는 정치적, 경제적, 사회적, 기술적 요인을 평가한 후입니다.

시장 참여자

이 보고서는 주요 내용을 다룹니다. 유기 및 무기 성장 전략으로 수의학 항생제 시장의 발전. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적인 성장 전략에 주력하고 있습니다. 시장에서 목격된 무기적 성장 전략은 인수, 파트너십 & 협력. 이러한 활동은 시장 참가자의 비즈니스 및 고객 기반 확장을 위한 길을 열었습니다. 동물용 항생제 시장의 시장 참가자들은 세계 시장에서 동물용 항생제에 대한 수요가 증가함에 따라 미래에 수익성 있는 성장 기회를 가질 것으로 예상됩니다. 아래에는 동물용 항생제 시장에 참여하는 몇몇 회사의 목록이 나와 있습니다.

이 보고서에는 동물용 항생제 시장의 주요 업체 프로필과 SWOT 분석 및 시장 전략도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 제공되는 제품 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발 등의 정보를 제공하는 업계 선두 기업에 중점을 두고 있습니다.
    • Zoetis, Inc. • 머크 & Co.• Bayer AG.• Sanofi• Eli Lilly• Ceva Sante Animale.• Boehringer Ingelheim GmbH• IPCA 연구소• Johnson & Johnson• Kyowa Hakko Kirin Pharma
The Insight Partner의 전담 연구 및 분석 팀은 고급 통계 전문 지식을 갖춘 숙련된 전문가로 구성되어 있으며 기존 연구에서 다양한 맞춤 옵션을 제공합니다.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Major restraint hampering the Veterinary Antibiotics Market growth?

Stringent Regulatory Restrictions is the major factors hampering the Veterinary Antibiotics Market growth.

Which is the fastest growing region in Veterinary Antibiotics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)

What is the expected CAGR of the Veterinary Antibiotics Market?

The Veterinary Antibiotics Market is estimated to witness a CAGR of 4.9% from 2023 to 2031

Which region higesh CAGR the Veterinary Antibiotics Market in 2023?

Asia Pacific region dominated the Veterinary Antibiotics Market in 2023

Who are the prominent players in Veterinary Antibiotics Market?

Zoetis, Inc., Merck & Co., Bayer AG., Sanofi, Eli Lilly are the major companies operating in the Veterinary Antibiotics Market

What years does this Veterinary Antibiotics Market?

The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Zoetis, Inc.
2. Merck & Co.
3. Bayer AG.
4. Sanofi
5. Eli Lilly
6. Ceva Sante Animale.
7. Boehringer Ingelheim GmbH
8. IPCA Laboratories
9. Johnson & Johnson
10. Kyowa Hakko Kirin Pharma
11. Merck
12. Mirabilia Sciences Pvt.
13. Novartis
14. Pfizer
15. Sanofi-Aventis
16. SRS Pharmaceuticals
17. Teva Pharmaceutical Industries Ltd
18. F. Hoffmann-La Roche
19. GlaxoSmithKline
20. Helsinn Healthcare

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.